Hospital News and Research

RSS

Curis presents vismodegib Phase II data in basal cell nevus syndrome at AACR meeting

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of interim Phase II clinical data on Hedgehog pathway inhibitor vismodegib in patients with basal cell nevus syndrome, which is also commonly referred to as Gorlin syndrome.

5 Apr 2011

Cubist enters license agreement with Teva to dismiss CUBICIN patent lawsuit

Cubist Pharmaceuticals, Inc. today announced that it has entered into a license agreement with Teva Parenteral Medicines, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd., which includes a stipulation by the parties requesting dismissal of the lawsuit filed by Cubist in the U.S. District Court for the District of Delaware relating to the Abbreviated New Drug Application filed by TPM with the U.S. Food and Drug Administration for a generic version of CUBICIN.

5 Apr 2011

Implementation of STEMI guidelines, protocols in hospitals without cardiac catheterization labs improves dramatically

The implementation of acute heart attack or ST-elevation myocardial infarction (STEMI) guidelines, protocols and standing orders in Minnesota community hospitals without cardiac catheterization labs has dramatically improved since 2003, according to a scientific poster that will be presented at the American College of Cardiology (ACC) Scientific Sessions in New Orleans, April 1-3.

5 Apr 2011

MIEMSS designates Sinai Hospital as Cardiac Interventional Center

The Maryland Institute for Emergency Medical Services Systems (MIEMSS) designated Sinai Hospital of Baltimore as a Cardiac Interventional Center on April 1, 2011.

5 Apr 2011

More physicians opting for salaries, other health care industry news

Even as a girl, Dr. Kate Dewar seemed destined to inherit the small-town medical practice of her grandfather and father. ... But when she finishes residency this summer, Dr. Dewar, 31, will not be going home. Instead, she will take a job as a salaried emergency room doctor at a hospital in Elmira, N.Y., two hours away.

5 Apr 2011

Risperdal Consta can reduce risk of hospitalisation in patients with schizophrenia

New data from an independent prospective study presented last week at the 19th European Congress of Psychiatry shows treatment with Risperdal Consta is associated with a lower risk of hospitalisation in patients with schizophrenia compared to treatment with other antipsychotics over a 12-month period.

5 Apr 2011

AGA guidelines recommend RFA for removal of precancerous cells in patients with Barrett's esophagus

New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans.

5 Apr 2011

PLC's RenalGuard REMEDIAL II trial against CIN presented at ACC.11

PLC Systems Inc., a company focused on innovative medical device technologies, announced that final results from the REMEDIAL II investigator-sponsored clinical trial of RenalGuard in Italy were presented today.

5 Apr 2011

Injection of stem cells may improve effectiveness of cardiac bypass surgery

In a new research study under way at the Methodist DeBakey Heart & Vascular Center, surgeons are adding a patient's own stem cells to the heart during cardiac bypass surgery. The goal of this research study is to determine whether the stem cell infusion will generate new blood vessels and improve heart function more than what is seen through bypass surgery alone.

5 Apr 2011

Vitamin D can reduce estrogen receptor-positive breast cancer

In mice models of breast cancer, researchers at the Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, found that vitamin D significantly reduced development of estrogen receptor-positive breast cancer both in lean and obese mice, but had no beneficial effect in estrogen receptor-negative cancer.

5 Apr 2011

Positive outcomes from Medtronic's Resolute drug-eluting stent against coronary artery disease

Results of two major clinical studies presented at ACC.11 - the 60th Annual Scientific Session & Expo of the American College of Cardiology - demonstrate that the Resolute drug-eluting stent from Medtronic, Inc., provides a positive and persistent treatment effect for a wide variety of patients with coronary artery disease.

5 Apr 2011

Health plans cut out expensive doctors and hospitals

The Los Angeles Times reports that thousands of California employers are cutting back on insurance expenses by restricting access to expensive doctors and hospitals. Also, Bloomberg looks at which companies are getting money from the new federal health law for retiree expenses includes some major US corporations.

5 Apr 2011

Inserm Transfert, MedImmune collaborate to advance medical science research

MedImmune, the global biologics business of AstraZeneca, and Inserm Transfert, the private subsidiary of the French National Institute of Health and Medical Research, today announced a three-year strategic collaboration to advance research across a range of therapeutic areas including oncology, respiratory, inflammation, and autoimmune diseases.

5 Apr 2011

New insight into Parkinson's disease

As Parkinson's Awareness Month gets underway, a Canadian-led international study is providing important new insight into Parkinson's disease and paving the way for new avenues for clinical trials.

5 Apr 2011

Vitamin D deficiency during pregnancy may raise risk of gestational diabetes: Study

A new study has shown that there is a connection between low Vitamin D levels and gestational diabetes. Vitamin D is one of the important vitamins during pregnancy. The researchers recommend that a pregnant woman should regularly get test done to check for vitamin D deficiency.

5 Apr 2011

Olivia’s cancer center receives $45 million for completion

Victorian Premier Ted Baillieu has finally sanctioned funds to complete the Olivia Newton-John Cancer and Wellness Centre. The Premier has committed almost $45 million to fit out the Austin Hospital project that was incomplete.

5 Apr 2011

Current Alzheimer Research publishes ExonHit's EHT 0202 Phase IIa results

ExonHit Therapeutics today announced the publication of Phase IIa results for EHT 0202, its lead candidate for the treatment of Alzheimer's disease, in the journal Current Alzheimer Research.

5 Apr 2011

Health Care REIT acquires $2.4 billion Genesis real estate assets

Health Care REIT, Inc. announced today that it has completed the $2.4 billion acquisition of substantially all of the real estate assets of privately-owned Genesis HealthCare, which was previously announced on February 28, 2011.

5 Apr 2011

Cardioxyl's CXL-1020 preclinical data against heart failure presented at ACC meeting

Cardioxyl Pharmaceuticals, Inc. announced today that it is presenting two abstracts from studies of its lead clinical candidate, CXL-1020, at the American College of Cardiology's 60th Annual Scientific Session & Expo in New Orleans, Louisiana.

5 Apr 2011

All Children's Hospital joins Johns Hopkins Medicine

All Children's Hospital, in St. Petersburg, Fla., is now a part of the Johns Hopkins Health System (JHHS) and a fully integrated member of Johns Hopkins Medicine (JHM). All Children's is the first U.S. hospital outside of the Baltimore/Washington, D.C., region to become integrated with JHM, which includes the Johns Hopkins University School of Medicine and The Johns Hopkins Hospital and Health System.

4 Apr 2011